Description: InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.
Home Page: www.inmodemd.com
Tavor Building
Yokne'am,
2069206
Israel
Phone:
972 4 909 6313
Officers
| Name | Title |
|---|---|
| Mr. Yair Malca | Chief Financial Officer |
| Mr. Alon Yaari | Vice President of Operations |
| Dr. Michael Kreindel | CTO & Director |
| Ms. Nava Tal-Launer | Chief Information Officer |
| Mr. Moshe Mizrahy | CEO & Director |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 8.5324 |
|---|---|
| Trailing PE: | 9.6879 |
| Price-to-Book MRQ: | 1.8357 |
| Price-to-Sales TTM: | 3.1 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 581 |